Immunology Letters 1991: Vol 30 Index

10 Pages·1991·2.8 MB·English

KEY WORD INDEX
Accesssory molecule Autoimmunity
CD8; CD2; Cytotoxic T cell; Transmembrane signalling; AIDS; HIV; Homosexual; Antinuclear antibody; Autoanti-
Specific target cell recognition; IFN-y (Reimann, A., 149) body (Argov, S., 31)
Affinity purification Autoimmunity
IFN-y antibodies; Human interferon-y (Viani, E., 53) Macrophage; Cytokine; Interleukin 1; Interleukin 6; Tumour
AIDS necrosis factor-a (Levine, J., 183)
CD4 lymphocyte counts; Prognosis; Hemophilia; HIV infec- Autologous mixed lymphocyte-tumour cell culture
tion; Immunology (Daniel, V., 27) Clonal expansion; T cell receptor; Lymphocyte-mediated
AIDS cytotoxicity (Stuber, G., 313)
HIV; Homosexual; Antinuclear antibody; Autoantibody;
Autoimmunity (Argov, S., 31) B cell
Algal assay Apoptosis; T cell (Fesus, L., 277)
Complement; Haemolysis; Quantification (Stefanski, V., 1) BLT esterase
Anergy Cytotoxic T cell; HLA B8; Competition (Fernan, A., 339)
Filariasis; Immunology, gp29; Pathology; Vaccine (Maizels, Biofilm
R. M., 249) Pseudomonas aeruginosa; Protease; Host defence; Phago-
Antibody cyte; Lymphocyte; Cytokine (Kharazmi, A., 201)
IL-6; IL-6 receptor; Platelet; DNP (Suzuki, H., 17) Bone marrow-derived macrophage
Antibody synthesis Cisplatin; Lipopolysaccharide; Granulocyte-macrophage
Pneumococcal polysaccharide; Conjugate vaccine; Tolerance colony stimulating factor; Macrophage colony stimulating
(Peeters, C. C. A. M., 267) factor; Interleukin-1; Tumour necrosis factor (Suresh, A., 93)
Antibody-mediated immune suppression
Autoimmune haemolytic anaemia; T-suppressor (Prigoshina, Calcitriol
T. B., 283) 22-Oxacalcitriol; Vitamin D analogue; Tumour necrosis fac-
Antigen presenting cell tor; Human mononuclear cells (Fujibayashi, S., 307)
Heat shock protein; Stress response; Phagocytosis; NADPH Cancer
oxidase; Monocyte-macrophage (Polla, B. S., 159) Immunosuppression; HSV-2-transformed fibroblasts; Trans-
Antigen presentation forming growth factor-8 (Das, M. R. P., 37)
HIV infection; Immunosuppression; Immunostimulation; Candida albicans
Dendritic cell (Knight, S. C., 213) MHC antigen; Immunoregulation (Ashman, R. B., 255)
Antigenic mapping CD2
“Tea-bag”’ peptide synthesis; Viral protein; Fmoc (Sallberg, Accessory molecule; CD8; Cytotoxic T cell; Transmembrane
M., 59) signalling; Specific target cell recognition; IFN-y (Reimann,
Antinuclear antibody A., 149)
AIDS; HIV; Homosexual; Autoantibody; Autoimmunity CD4 antigen
(Argov, S., 31) Lactotransferrin; Lactoferrin; Helper activity; Thymocyte
Apoptosis (Zimecki, M., 119)
T cell; B cell (Fesus, L., 277) CD4 lymphocyte counts
Autoantibody Prognosis; Hemophilia; HIV infection; AIDS; Immunology
AIDS; HIV; Homosexual; Antinuclear antibody; Autoimmu- (Daniel, V., 27)
nity (Argoy, S., 31) CD8
Autoantibodies to cytokines Accessory molecule; CD2; Cytotoxic T cell; Transmembrane
Serum antibody to IL-la; RIA; ELISA; Autoimmune disease signalling; Specific target cell recognition; IFN-y (Reimann,
(Hansen, M. B., 133) A., 149)
Autoimmune disease Cell proliferation
Serum antibody to IL-la; Autoantibodies to cytokines; RIA; Insulinoma; Insulin secretion; Interleukin; Interferon; G pro-
ELISA (Hansen, M. B., 133) tein (SjOholm, A., 81)
Autoimmune haemolytic anaemia Cell-mediated immunity
T-suppressor; Antibody-mediated immune suppression Neopterin; Tumour necrosis factor (Barak, M., 101)
(Prigoshina, T. B., 283)
Central nervous system ELISA
Neutrophil; Macrophage; Microglia; Inflammation; Recruit- FK506; Interleukin-2 receptor; Human lymphocyte; Flow
ment (Andersson, P.-B., 177) cytometry (Karlsson, H., 129)
Chronic inflammation ELISA
IL-1; Lymphocyte migration (Dawson, J., 319) Serum antibody to IL-la; Autoantibodies to cytokines; RIA;
Circulation residence time Autoimmune disease (Hansen, M. B., 133)
Immunoliposome; Immunogenicity (Phillips, N. C., 291) Embryo
Cisplatin Immunosuppressor factor; Pregnancy; In vitro fertilization
Bone marrow-derived macrophage; Lipopolysaccharide; and embryo transfer (Bose, R., 325)
Granulocyte-macrophage colony stimulating factor; Macro- Erythrocyte membrane
phage colony stimulating factor; Interleukin-l1; Tumour In vitro immunization; Glycophorin A; Monoclonal anti-
necrosis factor (Suresh, A., 93) body (Kolberg, J., 87)
Clonal expansion
Autologous mixed lymphocyte-tumour cell culture; T cell Filariasis
receptor; Lymphocyte-mediated cytotoxicity (Stuber, G., 313) Immunology; gp29; Anergy, Pathology; Vaccine (Maizels,
Competition R. M., 249)
Cytotoxic T cell; HLA B8; BLT esterase (Fernan, A., 339) FK506
Complement Interleukin-2 receptor; Human lymphocyte; Flow cytometry;
Algal assay; Haemolysis; Quantification (Stefanski, V., 1) ELISA (Karlsson, H., 129)
Conjugate vaccine Flow cytometry
Pneumococcal polysaccharide; Antibody synthesis; Toler- FK506; Interleukin-2 receptor; Human lymphocyte; ELISA
ance (Peeters, C. C. A. M., 267) (Karlsson, H., 129)
Cytokine Fmoc
TNF effect; Toxin; Malaria (Playfair, J. H. L., 145) “Tea-bag” peptide synthesis; Viral protein; Antigenic map-
Cytokine ping (Sallberg, M., 59)
Autoimmunity; Macrophage; Interleukin 1; Interleukin 6;
Tumour necrosis factor-a (Levine, J., 183) G protein
Cytokine Insulinoma; Insulin secretion; Cell proliferation; Interleukin;
Intracellular pathogen; Killing (Liew, F. Y., 193) Interferon (Sjoholm, A., 81)
Cytokine Genetic regulation
Pseudomonas aeruginosa; Biofilm; Protease; Host defence; Lsh gene; Macrophage priming/activation; Resistance
Phagocyte; Lymphocyte (Kharazmi, A., 201) (Blackwell, J. M., 241)
Cytolytic T lymphocyte Glycophorin A
Peptide; MHC class I; Photoaffinity labelling (Cerottini, In vitro immunization; Erythrocyte membrane; Monoclonal
J.-C., 171) antibody (Kolberg, J., 87)
Cytotoxic T cell gp29
Accessory molecule; CD8; CD2; Transmembrane signalling; Filariasis; Immunology; Anergy; Pathology; Vaccine
Specific target cell recognition; IFN-y (Reimann, A., 149) (Maizels, R. M., 249)
Cytotoxic T lymphocyte Granulocyte-macrophage colony stimulating factor
Peptide vaccination; Virus infection; Virus-induced tumor; Bone marrow-derived macrophage; Cisplatin; Lipopolysac-
Immunotherapy; Immunoprophylaxis (Kast, W. M., 229) charide; Macrophage colony stimulating factor; Interleukin-
Cytotoxic T cell 1; Tumour necrosis factor (Suresh, A., 93)
HLA B8; Competition; BLT esterase (Fernan, A., 339)
Haemolysis
Dendritic cell Complement; Algal assay; Quantification (Siefanski, V., 1)
Antigen presentation; HIV infection; Immunosuppression; Haemophilia
Immunostimulation (Knight, S. C., 213) CD4 lymphocyte counts; Prognosis; HIV infection; AIDS;
Dextran B-1355 Immunology (Daniel, V., 27)
Idiotype; T cell; Network; MI04E (Masaki, H., 107) Heat shock protein
DNA modification Stress response; Phagocytosis; NADPH oxidase; Monocyte-
Osmium tetroxide; Structural probe; Monoclonal antibody macrophage; Antigen presenting cell (Polla, B. S., 159)
(Kabakov, A. E., 23) Heat shock
DNP Lymphocyte; Heat shock protein; Hyperthermia (Ghassemi,
IL-6; Antibody; IL-6 receptor; Platelet (Suzuki, H., 17) M., 333)
Drug Heat shock protein
Vaccine; Parasitic disease (Gutteridge, W. E., 261) Heat shock; Lymphocyte; Hyperthermia (Ghassemi, M., 333)
Helper activity
ELISA Lactotransferrin; Lactoferrin; Thymocyte; CD4 antigen
Multiple antigen peptide; Malaria, Plasmodium malariae; (Zimecki, M., 119)
Immunoassay (Habluetzel, A., 75)
352
Heparin Immunology
Immunosuppressive agent; Naive cell; Memory cell (Korezak- CD4 lymphocyte counts; Prognosis; Hemophilia; HIV infec-
Kowalska, G., 125) tion; AIDS (Daniel, V., 27)
HIV Immunology
AIDS; Homosexual; Antinuclear antibody; Autoantibody; Filariasis; gp29; Anergy, Pathology; Vaccine (Maizels, R. M.,
Autoimmunity (Argov, S., 31) 249)
HIV Immunoprophylaxis
Monocyte; Leukocyte adhesion molecule; Inhibition ofi nfec- Cytotoxic T lymphocyte; Peptide vaccination; Virus infec-
tion (Kalter, D. C., 219) tion; Virus-induced tumor; Immunotherapy (Kast, W. M.,
HIV infection 229)
CD4 lymphocyte counts; Prognosis; Haemophilia; AIDS; Immunoregulation
Immunology (Daniel, V., 27) Candida albicans; MHC antigen (Ashman, R. B., 255)
HIV infection Immunostimulation
Antigen presentation; Immunosuppression; Immunostimu- Antigen presentation; HIV infection; Immunosuppression;
lation; Dendritic cell (Knight, S. C., 213) Dendritic cell (Knight, S. C., 213)
HLA B8 Immunosuppression
Cytotoxic T cell; Competition; BLT esterase (Fernan, A., 339) Cancer; HSV-2-transformed fibroblasts; Transforming
Homosexual growth factor-6 (Das, M. R. P., 37)
AIDS; HIV; Antinuclear antibody; Autoantibody; Autoim- Immunosuppressive agent
munity (Argov, S., 31) Heparin; Naive cell; Memory cell (Korczak-Kowalska, G.,
Host defence 125)
Pseudomonas aeruginosa; Biofilm; Protease; Phagocyte; Immunosuppression
Lymphocyte; Cytokine (Kharazmi, A., 201) Antigen presentation; HIV infection; Immunostimulation;
HSV-2-transformed fibroblasts Dendritic cell (Knight, S. C., 213)
Immunosuppression; Cancer; Transforming growth factor-@ Immunosuppressor factor
(Das, M. R. P., 37) Embryo; Pregnancy; In vitro fertilization and embryo transfer
Human interferon-y (Bose, R., 325)
IFN-y antibodies; Affinity purification (Viani, E., 53) Immunotherapy
Human lymphocyte Cytotoxic T lymphocyte; Peptide vaccination; Virus infec-
FK506; Interleukin-2 receptor; Flow cytometry; ELISA tion; Virus-induced tumor; Immunoprophylaxis (Kast,
(Karlsson, H., 129) W. M., 229)
Human mononuclear cells In vitro fertilization and embryo transfer
22-Oxacalcitriol; Vitamin D analogue; Calcitriol; Tumour Immunosuppressor factor; Embryo; Pregnancy (Bose, R.,
necrosis factor (Fujibayashi, S., 307) 325)
Hyperthermia In vitro immunization
Heat shock; Lymphocyte; Heat shock protein (Ghassemi, M., Erythrocyte membrane; Glycophorin A; Monoclonal anti-
333) body (Kolberg, J., 87)
Inflammation
Idiotype Neutrophil; Macrophage; Microglia; Central nervous system;
T cell; Network; MI04E; Dextran B-1355 (Masaki, H., 107) Recruitment (Andersson, P.-B., 177)
IFN-y Inhibition of infection
Accessory molecule; CD8; CD2; Cytotoxic T cell; Transmem- HIV; Monocyte; Leukocyte adhesion molecule (Kalter, D. C.,
brane signalling; Specific target cell recognition (Reimann, 219)
A., 149) Insulin secretion
IFN-y antibodies Insulinoma; Cell proliferation; Interleukin; Interferon; G
Human interferon-y; Affinity purification (Viani, E., 53) protein (Sjoholm, A., 81)
IL-1 Insulinoma
Lymphocyte migration; Chronic inflammation (Dawson, J., Insulin secretion; Cell proliferation; Interleukin; Interferon;
319) G protein (SjOholm, A., 81)
IL-6 Interferon
Antibody; IL-6 receptor; Platelet; DNP (Suzuki, H., 17) Insulinoma; Insulin secretion; Cell proliferation; Interleukin;
IL-6 receptor G protein (Sjoholm, A., 81)
IL-6; Antibody; Platelet; DNP (Suzuki, H., 17) Interleukin 1
Immunity Interleukin 6; Lipopolysaccharide; Muramyl dipeptide;
Mycobacterium tuberculosis; T cell (Orme, I. M., 207) Poly(I:C); Silica (Sarih, M., 69)
Immunoassay Interleukin 6
Multiple antigen peptide; ELISA; Malaria; Plasmodium Interleukin 1; Lipopolysaccharide; Muramyl dipeptide;
matariae (Habluetzel, A., 75) Poly(1:C); Silica (Sarih, M., 69)
Immunogencity Interleukin
Immunoliposome; Circulation residence time (Phillips, Insulinoma; Insulin secretion; Cell proliferation; Interferon;
N. C., 291) G protein (Sjoholm, A., 81)
353
Interleukin-1 Lymphocyte-mediated cytotoxicity
Bone marrow-derived macrophage; Cisplatin; Lipopolysac- Autologous mixed lymphocyte-tumour cell culture; Clonal
charide; Granulocyte-macrophage colony stimulating factor; expansion; T cell receptor (Stuber, G., 313)
Macrophage colony stimulating factor; Tumour necrosis fac- Lymphocyte migration
tor (Suresh, A., 93) IL-1; Chronic inflammation (Dawson, J., 319)
Interleukin-2 receptor Lymphocyte
FK506; Human lymphocyte; Flow cytometry; ELISA (Karls- Heat shock; Heat shock protein; Hyperthermia (Ghassemi,
son, H., 129) M., 333)
Interleukin 1 Lymphokine regulation
Autoimmunity; Macrophage; Cytokine; Interleukin 6; Superantigen; T cell anergy (O’Hehir, R. E., 165)
Tumour necrosis factor-a (Levine, J., 183)
Interleukin 6 M104E
Autoimmunity; Macrophage; Cytokine; Interleukin 1; Idiotype; T cell; Network; Dextran B-1355 (Masaki, H., 107)
Tumour necrosis factor-a (Levine, J., 183) MHC antigen
Intracellular pathogen Candida albicans; Immunoregulation (Ashman, R. B., 255)
Cytokine; Killing (Liew, F. Y., 193) MHC class I
Intrathymic apoptosis Peptide; Photoaffinity labelling; Cytolytic T lymphocyte
Thymulin regulation; Thymus hormone secretion; Stress and (Cerottini, J.-C., 171)
thymic function; Sound stress in the immune system (Folch, Macrophage colony stimulating factor
H., 301) Bone marrow-derived macrophage; Cisplatin; Lipopolysac-
charide; Granulocyte-macrophage colony stimulating factor;
Jurkat cell line Interleukin-1; Tumour necrosis factor (Suresh, A., 93)
Protein kinase C inhibition; T lymphoblast (Columelli, S., Macrophage
297) Neutrophil; Microglia; Inflammation; Central nervous sys-
tem; Recruitment (Andersson, P.-B., 177)
Killing Macrophage
Cytokine; Intracellular pathogen (Liew, F. Y., 193) Autoimmunity; Cytokine; Interleukin 1; Interleukin 6;
Tumour necrosis factor-a (Levine, J., 183)
Lactoferrin Macrophage priming/activation
Lactotransferrin; Helper activity; Thymocyte; CD4 antigen Lsh gene; Genetic regulation; Resistance (Blackwell, J. M.,
(Zimecki, M., 119) 241)
Lactotransferrin Malaria
Lactoferrin; Helper activity; Thymocyte; CD4 antigen Cytokine; TNF effect; Toxin (Playfair, J. H. L., 145)
(Zimecki, M., 119) Malaria
Lathyrus ochrus isolectin Plasmodium falciparum; Thalassaemia; Neoantigen (Luzzi,
Vicieae lectin; Monoclonal antibody; Sequential epitopes G. A., 233)
(Lueken, K., 47) Malaria, Plasmodium malariae
Leprosy Multiple antigen peptide; ELISA; Immunoassay (Habluetzel,
rIL-2; Resistance to infection (Kaplan, G., 199) A., 75)
Leukocyte adhesion molecule Memory cell
HIV; Monocyte; Inhibition of infection (Kalter, D. C., 219) Heparin; Immunosuppressive agent; Naive cell (Korczak-
Lipopolysaccharide Kowalska, G., 125)
Interleukin 1; Interleukin 6; Muramyl dipeptide; Poly(I:C); Microglia
Silica (Sarih, M., 69) Neutrophil; Macrophage; Inflammation; Central nervous
Lipopolysaccharide system; Recruitment (Andersson, P.-B., 177)
Bone marrow-derived macrophage; Cisplatin; Granulocyte- Monoclonal antibody
macrophage colony stimulating factor; Macrophage colony DNA modification; Osmium tetroxide; Structural probe
stimulating factor; Interleukin-l; Tumour necrosis factor (Kabakov, A. E., 23)
(Suresh, A., 93) Monoclonal antibody
Lsh gene Lathyrus ochrus isolectin; Vicieae lectin; Sequential epitopes
Macrophage priming/activation; Genetic regulation; Resist- (Lueken, K., 47)
ance (Blackwell, J. M., 241) Monoclonal antibody
Lymphocytes In vitro immunization; Erythrocyte membrane; Glycophorin
PGE2; PGE2 receptors; Tumour (Elkashab, M., 7) A (Kolberg, J., 87)
Lymphocyte subpopulation Monocyte
Splenectomy; Soluble CD8; Soluble CD4; Suppressor cell HIV; Leukocyte adhesion molecule; Inhibition of infection
(Weiss, C., 113) (Kalter, D. C., 219)
Lymphocyte Monocyte-macrophage
Pseudomonas aeruginosa; Biofilm; Protease; Host defence; Heat shock protein; Stress response; Phagocytosis; NADPH
Phagocyte; Cytokine (Kharazmi, A., 201) oxidase; Antigen presenting cell (Polla, B. S., 159)
354
Multiple antigen peptide Plasmodium falciparum
ELISA; Malaria, Plasmodium malariae; immunoassay Malaria; Thalassaemia; Neoantigen (Luzzi, G. A., 233)
(Habluetzel, A., 75) Platelet
Muramyl dipeptide IL-6; Antibody; IL-6 receptor; DNP (Suzuki, H., 17)
Interleukin 1; Interleukin 6; Lipopolysaccharide; Poly(1:C); Pneumococcal polysaccharide
Silica (Sarih, M., 69) Conjugate vaccine; Antibody synthesis; Tolerance (Peeters,
Mycobacterium tuberculosis C. C. A. M., 267)
T cell; Immunity (Orme, I. M., 207) Poly(I:C)
Interleukin 1; Interleukin 6; Lipopolysaccharide; Muramyl
NADPH oxidase dipeptide; Silica (Sarih, M., 69)
Heat shock protein; Stress response; Phagocytosis; Pregnancy
Monocyte-macrophage; Antigen presenting cell (Polla, B. S., Immunosuppressor factor; Embryo; In vitro fertilization and
159) embryo transfer (Bose, R., 325)
Naive cell Prognosis
Heparin; Immunosuppressive agent; Memory cell (Korczak- CD4 lymphocyte counts; Hemophilia; HIV infection; AIDS;
Kowalska, G., 125) Immunology (Daniel, V., 27)
Neoantigen Protease
Malaria; Plasmodium falciparum; Thalassaemia (Luzzi, Pseudomonas aeruginosa; Biofilm; Host defence; Phago-
G. A., 233) cyte; Lymphocyte; Cytokine (Kharazmi, A., 201)
Neopterin Protein kinase C inhibition
Cell-mediated immunity; Tumour necrosis factor (Barak, M., Jurkat cell line; T lymphoblast (Columelli, S., 297)
101) Pseudomonas aeruginosa
Network Biofilm; Protease; Host defence; Phagocyte; Lymphocyte;
Idiotype; T cell; MI04E; Dextran B-1355 (Masaki, H., 107) Cytokine (Kharazmi, A., 201)
Neutrophil
Macrophage; Microglia; Inflammation; Central nervous sys- Quantification
tem; Recruitment (Andersson, P.-B., 177) Complement; Algal assay; Haemolysis (Stefanski, V., 1)
Osmium tetroxide RIA
DNA modification; Structural probe; Monoclonal antibody Serum antibody to IL-la; Autoantibodies to cytokines; ELI-
(Kabakov, A. E., 23) SA; Autoimmune disease (Hansen, M. B., 133)
22-Oxacalcitriol Recruitment
Vitamin D analogue; Calcitriol; Tumour necrosis factor; Hu- Neutrophil; Macrophage; Microglia; Inflammation; Central
man mononuclear cells (Fujibayashi, S., 307) nervous system (Andersson, P.-B., 177)
Resistance to infection
PGE2 rIL-2; Leprosy (Kaplan, G., 199)
PGE2 receptors; Lymphocytes; Tumour (Elkashab, M., 7) Resistance
PGE2 receptors Lsh gene; Macrophage priming/activation; Genetic regula-
PGE2; Lymphocytes; Tumour (Elkashab, M., 7) tion (Blackwell, J. M., 241)
Parasitic disease rIL-2
Vaccine; Drug (Gutteridge, W. E., 261) Resistance to infection; Leprosy (Kaplan, G., 199)
Pathology
Filariasis; Immunology; gp29; Anergy; Vaccine (Maizels, Sequential epitopes
R. M., 249) Lathyrus ochrus isolectin; Vicieae lectin; Monoclonal anti-
Peptide body (Lueken, K., 47)
MHC class |; Photoaffinity labelling; Cytolytic T lymphocyte Serum antibody to IL-la
(Cerottini, J.-C., 171) Autoantibodies to cytokines; RIA; ELISA; Autoimmune dis-
Peptide vaccination ease (Hansen, M. B., 133)
Cytotoxic T lymphocyte; Virus infection; Virus-induced Silica
tumor; Immunotherapy; Immunoprophylaxis (Kast, W. M., Interleukin 1; Interleukin 6; Lipopolysaccharide; Muramyl
229) dipeptide; Poly(I:C) (Sarih, M., 69)
Phagocyte Soluble CD8
Pseudomonas aeruginosa; Biofilm; Protease; Host defence; Splenectomy; Soluble CD4; Lymphocyte subpopulation;
Lymphocyte; Cytokine (Kharazmi, A., 201) Suppressor cell (Weiss, C., 113)
Phagocytosis Soluble CD4
Heat shock protein; Stress response; NADPH oxidase; Splenectomy; Soluble CD8; Lymphocyte subpoulation; Sup-
Monocyte-macrophage; Antigen presenting cell (Polla, B. S., pressor cell (Weiss, C., 113)
159) Sound stress in the immune system
Photoaffinity labelling Thymulin regulation; Thymus hormone secretion; Stress and
Peptide; MHC class I; Cytolytic T lymphocyte (Cerottini, thymic function; Intrathymic apoptosis (Folch, H., 301)
J.-C., 171)
355
Specific target cell recognition Thymus hormone secretion
Accessory molecule; CD8; CD2; Cytotoxic T cell; Transmem- Thymulin regulation; Stress and thymic function; Intrathym-
brane signalling; IFN-y (Reimann, A., 149) ic apoptosis; Sound stress in the immune system (Folch, H.,
Splenectomy 301)
Soluble CD8; Soluble CD4; Lymphocyte subpopulation; Sup- Tolerance
pressor cell (Weiss, C., 113) Pneumococcal polysaccharide; Conjugate vaccine; Antibody
Stress and thymic function synthesis (Peeters, C. C. A. M., 267)
Thymulin regulation; Thymus hormone secretion; Intrathym- Toxin
ic apoptosis; Sound stress in the immune system (Folch, H., Cytokine; TNF effect; Malaria (Playfair, J. H. L., 145)
301) Transforming growth factor-8
Stress response Immunosuppression; Cancer; HSV-2-transformed fibro-
Heat shock protein; Phagocytosis; NADPH _ oxidase; blasts (Das, M. R. P., 37)
Monocyte-macrophage; Antigen presenting cell (Polla, B. S., Transmembrane signalling
159) Accessory molecule; CD8; CD2; Cytotoxic T cell; Specific tar-
Structural probe get cell recognition; IFN-y (Reimann, A., 149)
DNA modification; Osmium tetroxide; Monoclonal anti- Tumour
body (Kabakov, A. E., 23) PGE2; PGE2 receptors; Lymphocytes (Elkashab, M., 7)
Superantigen Tumour necrosis factor
T cell anergy; Lymphokine regulation (O’Hehir, R. E., 165) Bone marrow-derived macrophage; Cisplatin; Lipopolysac-
Suppressor cell charide; Granulocyte-macrophage colony stimulating factor;
Splenectomy; Soluble CD8; Soluble CD4; Lymphocyte sub- Macrophage colony stimulating factor; Interleukin-1 (Suresh,
population (Weiss, C., 113) A., 93)
Tumour necrosis factor
T cell Cell-mediated immunity; Neopterin (Barak, M., 101)
Idiotype; Network; M104E; Dextran B-1355 (Masaki, H., 107) Tumour necrosis factor-a
T cell Autoimmunity; Macrophage; Cytokine; Interleukin 1; Inter-
Mycobacterium tuberculosis; Immunity (Orme, |. M., 207) leukin 6 (Levine, J., 183)
T cell Tumour necrosis factor
Apoptosis; B cell (Fesus, L., 277) 22-Oxacalcitriol; Vitamin D analogue; Calcitriol; Human
T cell anergy mononuclear cells (Fujibayashi, S., 307)
Superantigen; Lymphokine regulation (O’Hehir, R. E., 165)
T cell receptor Vaccine
Autologous mixed lymphocyte-tumour cell culture; Clonal Filariasis; Immunology; gp29; Anergy; Pathology (Maizels,
expansion; Lymphocyte-mediated cytotoxicity (Stuber, G., R. M., 249)
313) Vaccine
““Tea-bag”’ peptide synthesis Drug; Parasitic disease (Gutteridge, W. E., 261)
Viral protein; Antigenic mapping; Fmoc (Sallberg, M., 59) Vicieae lectin
T lymphoblast Lathyrus ochrus isolectin; Monoclonal antibody; Sequential
Jurkat cell line; Protein kinase C inhibition (Columelli, S., epitopes (Lueken, K., 47)
297) Viral protein
T-suppressor “Tea-bag” peptide synthesis; Antigenic mapping; Fmoc (Sall-
Autoimmune haemolytic anaemia; Antibody-mediated im- berg, M., 59)
mune suppression (Prigoshina, T. B., 283) Virus infection
TNF effect Cytotoxic T lymphocyte; Peptide vaccination; Virus-induced
Cytokine; Toxin; Malaria (Playfair, J. H. L., 145) tumor; Immunotherapy; Immunoprophylaxis (Kast, W. M.,
Thalassaemia 229)
Malaria; Plasmodium falciparum; Neoantigen (Luzzi, G. A., Virus-induced tumor
233) Cytotoxic T lymphocyte; Peptide vaccination; Virus infec-
Thymocyte tion; Immunotherapy; Immunoprophylaxis (Kast, W. M.,
Lactotransferrin; Lactoferrin; Helper activity; CD4 antigen 229)
(Zimecki, M., 119) Vitamin D analogue
Thymulin regulation 22-Oxacalcitriol; Calcitriol; Tumour necrosis factor; Human
Thymus hormone secretion; Stress and thymic function; In- mononuclear cells (Fujibayashi, S., 307)
trathymic apoptosis; Sound stress in the immune system
(Folch, H., 301)
356
AUTHOR INDEX
Adam, A., see Sarih, M., Darcy, F., Foudrinier, F., Mougeot, G., Decoster, A., Ca-
Ajioka, J. W., see Blackwell, J. M., 241 ron, A., Marx-Chemla, C., Capron, A. and Pinon,
Andersson, P.-B., Perry, V. H. and Gordon, S., The CNS J. M., Diagnostic value of specific IgA antibodies in
acute inflammatory response to excitotoxic neuronal AIDS patients with 7Joxoplasma infection: a bicentric
cell death, 177 evaluation (Letter to the Editor), 345
Anzai, M., see Suzuki, H.., 17 Das, M. R. P., Gridley, D. S. and Kettering, J. D., Sup-
Argov, S., Schattner, A., Burstein, R., Handzal, Z. T., pression of immune responses by herpes virus type 2-
Shoenfeld, Y. and Bentwich, Z., Autoantibodies in transformed murine tumor cells, 37
male homosexuals and HIV infection, 31 Dawson,J. , Edwards, J. C. W., Sedgwick, A. D. and Lees,
Ashman, R. B., Enhancement of MHC Class II antigen P., IL-l@ inhibits lymphocyte migration into a site of
expression by exposure to Candida albicans, 255 chronic inflammation, 319
Atkinson, S. E., see Blackwell, J. M., 241 De Francesco, M., see Viani, E., 53
Decoster, A., see Darcy, F., 345
Balsari, A., see Viani, E., 53
Barak, M. and Gruener, N., Neopterin augmentation of Edwards, J. C. W., see Dawson, J., 319
tumor necrosis factor production, 101 Ehrfeld, A., see Reimann, A., 149
Barton, C. H., see Blackwell, J. M., 241 Eichmann, K., see Reimann, A., 149
Beller, D. I., see Levine, J., 183 Elkashab, M. and Lala, P., PGE, receptors on murine
Bendtzen, K., see Hansen, M. B., 133 splenic lymphocytes: effects of tumor bearing, 7
Bentwich, Z., see Argov, S., 31 Emili, A., see Phillips, N. C., 291
Bianchi, E., see Habluetzel, A.., 75 Esposito, F., see Habluetzel, A., 75
Blackwell, J. M., Roach, T. I. A., Atkinson, S. E., Ajio- Esquivel, P., see Folch, H., 301
ka, J. W., Barton, C. H. and Shaw, M.-A., Genetic Evenberg, D., see Peeters, C. C. A. M., 267
regulation of macrophage priming/activation: the Lsh
gene story, 241 Fernan, A., Burrows, S. R., Moss, D. J., Saul, A. and
Blanchard, D., see Kolberg, J., 87 Suhrbier, A., Inhibition of HLA B8-restricted recogni-
Bose, R., Properties of human pre- and post-implantation tion by unrelated peptides: evidence for allosteric inhi-
embryo-associated immunosuppressor factor(s), 325 bition, 339
Bourne, Y., see Lueken, K.., 47 Fesus, L., Apoptosis fashions T and B cell repertoire
Braun, E., see Daniel, V., 27 (Minireview), 277
Buelow, R., see O’Hehir, R. E., 165 Flamminio, G., see Viani, E., 53
Burrows, S. R., see Fernan, A., 339 Folch, H., Ojeda, F. and Esquivel, P., Rise in thymocyte
Burstein, R., see Argoyv, S., 31 number and thymulin serum level induced by noise, 301
Fontalin, L. N., see Prigozhina, T. B., 283
Cambillau, C., see Lueken, K.., 47 Foresti, I., see Viani, E.., 53
Capron, A., see Darcy, F., 345 Foudrinier, F., see Darcy, F., 345
Caron, A., see Darcy, F., 345 Fujibayashi, S., Suzuki, S., Okano, K., Naitoh, T., Kataba-
Caruso, A., see Viani, E., 53 mi, T. and Someya, K., The weak calcemic vitamin D,
Cerottini, J.-C. and Luescher, I. F., Direct analysis of pep- analogue 22-oxacalcitriol suppresses the production of
tide binding to cell-associated MHC class I molecules, 171 tumor necrosis factor-a by peripheral mononuclear
Chan, A., see Stuber, G., 313 cells, 307
Chernyakhovskaya, I. Yu., see Prigozhina, T. B., 283 Fujimoto, T., see Masaki, H., 107
Clinchy, B., see Reimann, A.., 149
Columelli, S., Houllier, A.-M. and Pérignon, J.-L., A pro- Gendelman, H. E., see Kalter, D. C., 219
tein kinCa inhsibietor y activityi s present in the human Ghassemi, M., Heydari, A. R. and Richardson, A., In-
T lymphoblast cell line Jurkat, 297 duction ofh eat shock proteinsi n lymphocytes increases
with mitogen stimulation, 333
Daniel, V., Weimer, R., Zimmermann, R., Huth-Kuhne, Goitsuka, R., see Suzuki, H., 17
A., Weisser, J., Braun, E. and Opelz, G., Improving Gordon, S., see Andersson, P.-B., 177
CD4* lymphocyte counts in HIV-infected hemophilia Graafsma, S. J., see Van Tits, L. J. H., 141
patients. A favourable prognostic indicator?, Gridley, D. S., see Das, M. R. P.,
Gruener, N., see Barak, M.., 101 Kupsch, J., see Reimann, A.,
Gutteridge, W. E., Control of parasitic diseases: a com- Kurniawan, A., see Maizels, R. M.,
plementary role for vaccines and drugs, 261
Gorski, A., see Korczak-Kowalska, G., 125 Lala, P., see Elkashab, M.,
Lamb, J. R., see O’Hehir, R. E.,
Haagmans, B., see Peeters, C. C. A. M., 267 Lees, P., see Dawson, J.,
Habluetzel, A., Pessi, A., Bianchi, E., Rotigliano, G. and Levine, J., Hartwell, D. and Beller, D. I., Imbalanced
Esposito, F., Multiple antigen peptides for specific de- cytokine production by macrophages from auto-
tection of antibodies to a malaria antigen in human immune-prone mice, 183
sera, 75 Liew, F. Y., Role of cytokines in killing of intracellular
Hamazaki, H., see Masaki, H.., 107 pathogens, 193
Handzel, Z. T., see Argoyv, S., 31 Lueken, K., Kolberg, J., Cambillau, C., Bourne, Y. and
Hansen, M. B., Svenson, M. and Bendtzen, K., Human Rougé, P., Monoclonal antibody 117,C-11 recognizes
anti-interleukin la antibodies, 133 three exposed regions on the surface of the Lathyrus
Hartwell, D., see Levine, J., 183 ochrus isolectin I, 47
Hasegawa, A., see Suzuki, H., 17 Luescher, I. F., see Cerottini, J.-C., 171
Heydari, A. R., see Ghassemi, M., 333 Luzzi, G. A., Merry, A. H., Newbold, C. I., Marsh, K.
Ho, A. D., see Weiss, C., 113 and Pasvol, G., Protection by a-thalassaemia against
Horiuchi, A., see Masaki, H.., 107 Plasmodium falciparum malaria: modified surface an-
Horiuchi, F., see Masaki, H., 107 tigen expression rather than impaired growth or cytoad-
Houllier, A.-M., see Columelli, S., 297 herence,
Hunstein, W., see Weiss, C., 113
Huth-Kuhne, A., see Daniel, V., 27 Macatonia, S. E., see Knight, S. C.,
Machnicki, M., see Zimecki, M..,
Irimajiri, K., see Masaki, H., 107 Maeda, Y., see Masaki, H.,
Magnius, L. O., see Sallberg, M.,
Kabakov, A. E., Podgorodnichenko, V. K. and Poveren- Maier, B., see Reimann, A..,
ny, A. M., A monoclonal antibody to DNA modified Maizels, R. M., Kurniawan, A., Selkirk, M. E. and Yaz-
with Osmium tetroxide/2,2’ -bipyridine, 23 danbakhsh, M., Immune response to filarial parasites,
Kalter, D. C., Gendelman, H. E. and Meltzer, M. S., Inhi- Mak, T. W., see Stuber, G.,
bition of human immunodeficiency virus in monocytes Marsh, K., see Luzzi, G. A..,
by monoclonal antibodies against leukocyte adhesion Marx-Chemla, C., see Darcy, F.,
molecules, 219 Masaki, H., Shirakawa, C., Matsuda, M., Morita, S.,
Kaplan, G., The role of rI[L-2 in the modulation ofc ellular Koyama, A., Horiuchi, F., Hamazaki, H., Fujimoto, T.,
immunity in resistance to infection, 199 Maeda, Y., Irimajiri, K. and Horiuchi, A., Induction
Karlsson, H., Truedsson, L. and Nassberger, L., The im- ofa nti-idiotypic T cells through a network mechanism,
munosuppressive agent FK506 inhibits in vitro expres- Matsuda, M., see Masaki, H.,
sion of membrane-bound and soluble interleukin-2 Mazurier, J., see Zimecki, M.,
receptors on resting but not on activated human lym- Melief, C. J. M., see Kast, W. M..,
phocytes, 129 Meltzer, M. S., see Kalter, D. C.,
Kast, W. M. and Melief, C. J. M., In vivo efficacy of Merry, A. H., see Luzzi, G. A.,
virus-derived peptides and virus-specific cytotoxic T Montreuil, J., see Zimecki, M.,
lymphocytes, 229 Morita, S., see Masaki, H..,
Katabami, T., see Fujibayashi, S., 307 Moss, D. J., see Fernan, A.,
Kettering, J. D., see Das, M. R. P., 37 Mougeot, G., see Darcy, F.,
Kharazmi, A., Mechanisms involved in the evasion of the
host defence by Pseudomonas aeruginosa, 201 Naitoh, T., see Fujibayashi, S.,
Kishimoto, T., see Suzuki, H., 17 Newbold, C. I., see Luzzi, G. A., .
Klein, E., see Stuber, G., 313 Norrby, E., see Sallberg, M.,
Knight, S.C, Patterson, S. and Macatonia, S. E., Nassberger, L., see Karlsson, H.,
Stimulatory and suppressive effects of infection of den-
dritic cells with HIV-1, 213 O’Hehir, R. E., Buelow, R., Yssel, H. and Lamb, J. R..,
Kolberg, J. and Blanchard, D., A mouse monoclonal anti- Staphylococcus aureus enterotoxin mediated specific
body against glycophorin A produced by in vitro stimu- non-responsiveness of human T cells,
lation with human red cell membranes, 87 Ohsugi, Y., see Suzuki, H.,
Kolberg, J., see Lueken, K., 47 Ojeda, F., see Folch, H.,
Korczak-Kowalska, G., Wierzbicki, P. and Gorski, A., Im- Okano, K., see Fujibayashi, S.,
munosuppression inhibits switch from naive to memo- Opelz, G., see Daniel, V.,
ry phenotype in human T lymphocytes, 125 Orme, I. M., The molecular targets of T cells in acquired
Koyama, A., see Masaki, H., 107 immunity to tuberculosis,
358
Pasvol, G., see Luzzi, G. A., Sodhi, A., see Suresh, A..,
Patterson, S., see Knight, S. C., 213 Solovjev, V. V., see Prigozhina, T. B.,
Peeters, C. C. A. M., Tenbergen-Meekes, A.-M., Haag- Someya, K., see Fujibayashi, S.,
mans, B., Evenberg, D., Poolman, J. T., Zegers, Souvannavong, V., see Sarih, M.,
B. J. M. and Rijkers, G. T., Pneumococcal conjugate Spik, G., see Zimecki, M.,
vaccines, 267 Stefanski, V. and Ruppell, H. G., A new quantitative as-
Perry, V. H., see Andersson, P.-B., 177 say for the determination of complement activity,
Pessi, A., see Habluetzel, A., 75 Stuber, G., Vanky, F., Wen, T., Chan, A., Klein, E. and
Phillips, N. C. and Emili, A., Immunogenicity of im- Mak, T. W., Predominant rearrangements of the T cell
munoliposomes, 291 receptor 6-chain gene in blood lymphocyte populations
Pinon, J. M., see Darcy, F., 345 stimulated with autologous tumor cells suggest clonal
Playfair, J., Toxins, cytokines, immunity and pathology, 145 T cell expansion in two of fourteen cases, 313
Podgorodnichenko, V. K., see Kabakov, A. E., 23 Suhrbier, A., see Fernan, A., 339
Polla, B. S., The heat shock response in human phago- Suresh, A. and Sodhi, A., Production of interleukin-1 and
cytes, 159 tumor necrosis factor by bone marrow-derived macro-
Pollara, P., see Viani, E., 53 phages: effect of cisplatin and lipopolysaccharide, 93
Poolman, J. T., see Peeters, C. C. A. M., 267 Suzuki, H., Yasukawa, K., Saito, T., Anzai, M., Goitsuka,
Poverenny, A. M., see Kabakov, A. E.., 23 R., Hasegawa, A., Ohsugi, Y., Taga, T. and Kishimoto,
Prigozhina, T. B., Fontalin, L. N., Chernyakhovskaya, T., Anti-murine IL-6 receptor antibody inhibits IL-6 ef-
I. Yu. and Solovjev, V. V., Autoimmune response in- fects in vivo, 17
duction and regulation in rat erythrocyte-immunized Suzuki, S., see Fujibayashi, S., 307
mice, 283 Svenson, M., see Hansen, M. B., 133
Pérignon, J.-L., see Columelli, S., 297
Taga, T., see Suzuki, H., 17
Reimann, A., Ehrfeld, A., Kupsch, J., Maier, B., Saizawa, Tenbergen-Meekes, A.-M., see Peeters, C. C. A. M., 267
K. M., Clinchy, B. and Eichmann, K., A comparative Truedsson, L., see Karlsson, H., 129
assessment of the roles of CD8 and CD2 in the func- Turano, A., see Viani, E., 53
tions of activated murine CD8+ T lympocytes,
Richardson, A., see Ghassemi, M., Vanky, F., see Stuber, G., 313
Rijkers, G. T., see Peeters, C. C. A. M., Van Tits, L. J. H. and Graafsma, S. J., Stress influences
Roach, T. I. A., see Blackwell, J. M., CD4+ lymphocyte counts (Letter to the Editor), 14]
Rotigliano, G., see Habluetzel, A., Viani, E., Flamminio, G., Caruso, A., Foresti, I., De Fran-
Rougé, P., see Lueken, K., cesco, M., Pollara, P., Balsari, A. and Turano, A.,
Rudén, U., see Sallberg, M., Purification of natural human IFN-y antibodies,
Ruppell, H. G., see Stefanski, V.,
Wahren, B., see Sallberg, M.,
Saito, T., see Suzuki, H., Weimer, R., see Daniel, V.,
Saizawa, K. M., see Reimann, A.., Weiss, C., Wulf, G., Ho, A. D. and Hunstein, W., Decrease
Sallberg, M., Rudén, U., Magnius, L. O., Norrby, E. and in soluble CD8 antigen levels in splenectomized pa-
Wahren, B., Rapid “tea-bag” peptide synthesis using tients as an index for reduced suppressor/cytotoxic cell
9-fluorenylmethoxycarbonyl (Fmoc) protected amino activity,
acids applied for antigenic mapping of viral proteins, 59 Weisser, J., see Daniel, V.,
Sarih, M., Souvannavong, V. and Adam, A., Defective Wen, T., see Stuber, G.,
production of interleukin 6 by macrophages from Wieczorek, Z., see Zimecki, M..,
C3H/HeJ mice: differential stimulation of interleukin Wierzbicki, P., see Korczak-Kowalska, G.,
1 and interleukin 6 induction, 69 Wulf, G., see Weiss, C.,
Saul, A., see Fernan, A.., 339
Schattner, A., see Argov, S., 31 Yasukawa, K., see Suzuki, H.,
Sedgwick, A. D., see Dawson, J., 319 Yazdanbakhsh, M., see Maizels, R. M..,
Selkirk, M. E., see Maizels, R. M., 249 Yssel, H., see O’Hehir, R. E.,
Shaw, M.-A., see Blackwell, J. M., 241
Shirakawa, C., see Masaki, H., 107 Zegers, B. J. M., see Peeters, C. C. A. M.,
Shoenfeld, Y., see Argoyv, S., 31 Zimecki, M., Mazurier, J., Machnicki, M., Wieczorek, Z.,
Sjohdlm, A., Cytokines inhibit proliferation and insulin Montreuil, J. and Spik, G., Immunostimulatory activi-
secretion by clonal rat insulinoma cells (RINmSF) non- ty of lactotransferrin and maturation of CD4~ CD8~-
synergistically and in a pertussis toxin-insensitive man- murine thymocytes,
ner, Zimmermann, R., see Daniel, V.,